Skip to content Skip to navigation

Phenomics Lab

High-throughput solutions for large-scale disease phenotyping.

We have established scalable, high-throughput phenotyping methods for characterizing human and mouse eye diseases. The mouse eye phenotype screening service is available to laboratories throughout the world. Through the development of cooperative laboratory networks, we hope to expand our screening effort.

Projects

We have established a scalable, multilevel, high-throughput phenotyping laboratory to identify mouse models for eye disease.

Capturing surgical events for careful clinical studies has always been a challenge.

News

Oct 19 2023 | Posted In: 20/20 Blog
  Palo Alto, CA — The eyes may be a window into the soul, but Stanford research scientists are now showing the eyes may also be a window into overall human health. 
Aug 9 2022 | Posted In: 20/20 Blog
 
Apr 18 2022 | Posted In: 20/20 Blog
Palo Alto, CA — A Wall Street Journal article on age-related retinal tears and detachments features an interview with Stanford’s Vinit Mahajan MD, PhD, professor of ophthalmology and vice chair for
Dec 10 2021 | Posted In: 20/20 Blog
Palo Alto, CA — In the operating room and clinic, Vinit Mahajan M.D., Ph.D., Stanford Ophthalmology vice chair for research and ChEM-H fellow, uses ocular drug implants (ODIs) to safely deliver steroids into the eye to treat a range of eye di
Nov 11 2021 | Posted In: 20/20 Blog
Palo Alto, CA —News outlets, fitness magazines, and health bloggers churn out hundreds of articles on the health benefits of exercise. And most people can tell you that exercise is an important factor in warding off heart disease, diabetes, cancer, and depression.
See more news

Publications

Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk., Velez, Gabriel, Nguyen Huy V., Chemudupati Teja, Ludwig Cassie A., Toral Marcus, Reddy Sunil, Mruthyunjaya Prithvi, and Mahajan Vinit B. , Mol Cancer, 2021 02 24, Volume 20, Issue 1, p.39, (2021)
Genetics of Uveitis., Cunningham, Emmett T., Pichi Francesco, Mahajan Vinit B., Rosenbaum James T., and Zierhut Manfred , Ocul Immunol Inflamm, 2021 Feb 17, Volume 29, Issue 2, p.215-218, (2021)
Telegenetics for inherited retinal diseases in the COVID-19 environment., Al-Moujahed, Ahmad, Kumar Aarushi, Chemudupati Teja, Tsang Stephen H., and Mahajan Vinit B. , Int J Retina Vitreous, 2021 Mar 29, Volume 7, Issue 1, p.25, (2021)
Molecular Characterization of a Rare Case of Bilateral Vitreoretinal T Cell Lymphoma through Vitreous Liquid Biopsy., Cani, Andi K., Toral Marcus A., Balikov Daniel A., Betz Bryan L., Hu Kevin, Liu Chia-Jen, Prifti Matthew V., Chinnaiyan Arul M., Tomlins Scott A., Mahajan Vinit B., et al. , Int J Mol Sci, 2021 Jun 05, Volume 22, Issue 11, (2021)
Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual Outcomes., Evans, Lucy P., Woll Addison W., Wu Shu, Todd Brittany P., Hehr Nicole, Hedberg-Buenz Adam, Anderson Michael G., Newell Elizabeth A., Ferguson Polly J., Mahajan Vinit B., et al. , J Neurotrauma, 2020 Mar 16, (2020)
Sex Does Not Influence Visual Outcomes After Blast-Mediated Traumatic Brain Injury but IL-1 Pathway Mutations Confer Partial Rescue., Evans, Lucy P., Boehme Nickolas, Wu Shu, Burghardt Elliot L., Akurathi Abhigna, Todd Brittany P., Newell Elizabeth A., Ferguson Polly J., Mahajan Vinit B., Dutca Laura M., et al. , Invest Ophthalmol Vis Sci, 2020 Oct 01, Volume 61, Issue 12, p.7, (2020)
See more publications